Filing Details
- Accession Number:
- 0001209191-15-071928
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-22 20:39:28
- Reporting Period:
- 2015-09-21
- Filing Date:
- 2015-09-22
- Accepted Time:
- 2015-09-22 20:39:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1394319 | Tracon Pharmaceuticals Inc. | TCON | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Square, West Tower 11F 1-5-1 Otemachi, Chiyoda-Ku Tokyo M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-09-21 | 15,000 | $14.27 | 1,598,370 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-21 | 3,200 | $15.45 | 1,595,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-22 | 21,226 | $13.63 | 1,573,944 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $14.00 to $14.75. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $15.05 to $15.77. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $13.02 to $14.02. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
